Lv31
374 积分 2023-10-19 加入
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
9天前
已完结
KRAS takes the road to destruction
28天前
已完结
Preclinical Pharmacokinetics of Erdafitinib, an FGFR Tyrosine Kinase Inhibitor, via LC‐MS/MS in Sprague Dawley Rats
1个月前
已完结
A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib
1个月前
已完结
Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor
1个月前
已完结
RASless MEFs as a Tool to Study RAS-Dependent and RAS-Independent Functions
1个月前
已完结
A tumour-derived organoid biobank maps cancer gene dependencies
1个月前
已关闭
Distribution, Metabolism, and Excretion of Gedatolisib in Healthy Male Volunteers After a Single Intravenous Infusion
1个月前
已完结
Guideline for the diagnosis and treatment of psoriasis in China （2018 complete edition）
1个月前
已完结
The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials
1个月前
已完结
皖公网安备34019202002308
